New Brain and Whole Body Tissue Clearing|Register Now
»
Genomics in Cancer Drug Discovery and Development
 
 

Genomics in Cancer Drug Discovery and Development, 1st Edition

 
Genomics in Cancer Drug Discovery and Development, 1st Edition,George Vande Woude,George Klein,Garret Hampton,Karol Sikora,ISBN9780120066964
 
 
 

Advances in Cancer Research

Vande Woude   &   Klein   &   Hampton   &   Sikora   

Academic Press

9780120066964

9780080471013

432

229 X 152

Print Book + eBook

USD 213.00
USD 355.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 180.00

eBook
eBook Overview

VST format:

DRM Free included formats: PDF

USD 175.00
Add to Cart
 
 

Description

The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever thematic volume in the series, focusing on the topic of genomics in cancer drug development. The chapters included in this book represent the cutting-edge information in the field and span such topics as Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics; Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches; The Application of siRNA Technology to Cancer Biology Discovery; Ribozyme Technology for Cancer Gene Target Identification and Validation; Cancer Cell-Based Genomic and Small Molecule Screens; Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines; Practices and Pitfalls of Mouse Cancer Models in Drug Discovery; Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers; Molecular Optical Imaging of Therapeutic Targets of Cancer; Cancer Drug Approval in the United States, Europe and Japan.

Readership

Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.

George Vande Woude

Affiliations and Expertise

Director, Van Andel Research Institute, Grand Rapids, MI, USA

View additional works by George F. Vande Woude

George Klein

Affiliations and Expertise

Karolinska Insitutet, Stockholm, Sweden

View additional works by George Klein

Garret Hampton

Affiliations and Expertise

Celgene Signal Research, San Diego, CA, U.S.A.

Karol Sikora

Affiliations and Expertise

Professor, Hammersmith Hospital, Hammersmith, U.K.

Genomics in Cancer Drug Discovery and Development, 1st Edition

Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics.
Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches.
The Application of siRNA Technology to Cancer Biology Discovery.
Ribozyme Technology for Cancer Gene Target Identification and Validation.
Cancer Cell-Based Genomic and Small Molecule Screens.
Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines.
Practices and Pitfalls of Mouse Cancer Models in Drug Discovery.
Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers.
Molecular Optical Imaging of Therapeutic Targets of Cancer.
Cancer Drug Approval in the United States, Europe and Japan.
 
 

Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Contact Us